March 26, 2019 / 8:48 AM / a month ago

BRIEF-Oxford Biomedica Says Japanese Approval Of Kymriah

March 26 (Reuters) - Oxford BioMedica PLC:

* JAPANESE APPROVAL OF KYMRIAH® (TISAGENLECLEUCEL)

* NOTES AN ANNOUNCEMENT BY NOVARTIS THAT JAPAN'S MINISTRY OF HEALTH, LABOR AND WELFARE (MHLW) HAS APPROVED KYMRIAH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below